Statistical Analysis of Variation in the Human Plasma Proteome

Abstract

Quantifying the variation in the human plasma proteome is an essential prerequisite for disease-specific biomarker detection. We report here on the longitudinal and individual variation in human plasma characterized by two-dimensional difference gel electrophoresis (2-D DIGE) using plasma samples from eleven healthy subjects collected three times over a two week period. Fixed-effects modeling was used to remove dye and gel variability. Mixed-effects modeling was then used to quantitate the sources of proteomic variation. The subject-to-subject variation represented the largest variance component, while the time-within-subject variation was comparable to the experimental variation found in a previous technical variability study where one human plasma sample was processed eight times in parallel and each was then analyzed by 2-D DIGE in triplicate. Here, 21 protein spots had larger than 50% CV, suggesting that these proteins may not be appropriate as biomarkers and should be carefully scrutinized in future studies. Seventy-eight protein spots showing differential protein levels between different individuals or individual collections were identified by mass spectrometry and further characterized using hierarchical clustering. The results present a first step toward understanding the complexity of longitudinal and individual variation in the human plasma proteome, and provide a baseline for improved biomarker discovery.

Proteomic sample preparation for blast wound characterization

“…Similarly, serum after high abundant protein removal from three patients was evaluated by 2-D DIGE, the gel image is shown in Figure 5A-D. DeCyder analysis detected 1200 total protein spots, which is a similar to or exceeds other reports of greater than 1000 2-D gel spots [9,12,14,15,23,24]. …”

Concordant Release of Glycolysis Proteins into the Plasma Preceding a Diagnosis of ER+ Breast Cancer

“…Additionally, the proteins in the complement and coagulation pathway are among the highest in abundance in plasma. They exhibit high inter-sample variability both across individuals and within samples taken from the same individual (33) due in part to sample preparation methodology (34, 35). In contrast, our findings with respect to the glycolysis pathway are supported by substantial evidence.…”

Differentially expressed urinary biomarkers in children with idiopathic nephrotic syndrome

“…A major strength of using iTRAQ in the study was the possibility to compare one patient's samples from both active NS and remission in the same experiment. This procedure circumvents inter individual variation which previously has been shown to exceed the variation in plasma proteome profiles induced by sampling at different times within the same subject [14]. Furthermore, this peptide-based method avoids solubility problems of proteins, which constitute a major concern for some proteins.…”